Publications

Re-Evaluation of the Bactericidal Activities and the Correlation between Disk Diffusion and MIC Methods for Testing Daptomycin and Vancomycin against S. aureus with Decreased Susceptibility (S) to Gylcopeptides, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activities of Cefepime and Piperacillin/Tazobactam against E. coli and Klebsiella spp. with ESBL-Phenotype Collected Worldwide, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Potential Role for Triple Antibiotic Ointment (TAO) Against Mupirocin-Resistant Staphylococci: A USA and Australian Clinical Isolate Sample, Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Daptomycin Resistance and Vancomycin Intermediate S. aureus in a Patient with Prolonged Antibiotic Therapy, Lead author: Mariani P, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Global Assessment of the Polymyxin B Activity Tested against 55,151 Clinical Strains of Gram-Negative Bacilli: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Spectrum and Potency of Dalbavancin Tested against 3,322 Gram-Positive Cocci Isolated in the USA Surveillance Program (2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Activity of Tigecycline (TIG) Tested Against Non-Fermentative Gram-Negative Bacilli (NFB), Including Imipenem-Non-Susceptible (IMP-NS) Strains, and ESBL-producing Enterobacteriaceae (ENT), Lead author: Fritsche TR, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Persistent Occurrence of Clonally Related Multi-Drug Resistant Acinetobacter Spp. Isolates Within the MYSTIC Programme Medical Centers (USA, 1999 – 2004), Lead author: Rhomberg PR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Potential Options for Parental Therapy of Community-Acquired Infections Caused by Levofloxacin-Resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Fritsche TR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Comparative Antimicrobial Spectrum and Potency of Meropenem Tested Against Enterobacteriaceae and Non-Fermentative Gram-Negative Bacilli: Report from the 2004 MYSTIC Program (USA), Lead author: Jones RN, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Comprehensive In Vitro Evaluation of Cefepime Combined with Aztreonam or Ampicilin/Sulbactam Against Multi-Drug Resistant Pseudomonas aeruginosa and Acinetobacter spp., Lead author: Sader HS, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Antimicrobial Activity of the Novel Peptide Deformylase Inhibitor LBM415 (NVP PDF-713) Against an International Collection of Respiratory Tract, Skin and Soft Tissue Pathogens (2004), Lead author: Watters A, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Influence of Errors Caused by Automated Systems in the Antimicrobial Susceptibility Rates of Pseudomonas aeruginosa against Selected Beta-Lactam Antimicrobials, Lead author: Sader HS, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

In Vitro Evaluation of Dalbavancin in Combination with Other Classes of Antimicrobial Agents, Lead author: Johnson DM, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Reproducibility of Daptomycin MIC Results Using Dry-Form Commercial Trays with Supplemental Calcium Content, Lead author: Rhomberg PR, presented at 105th annual American Society for Microbiology General Meeting (ASM), June 5 – 9, 2005, Atlanta, GA

Evaluation of Bactericidal Activity of Daptomycin and Vancomycin Tested Against Staphylococcus aureus (VISA, hVISA, and wild-types), Lead author: Sader HS, presented at 8th annual International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, May 22 – 24, 2005, Charleston, South Carolina

Antimicrobial Activity and Spectrum of Cefepime Tested Against 65,746 Clinical Strains from North American Medical Centres: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2004, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Comparative Activity of Oral and Parental Cephalosporins Against Multi-drug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1997-2003), Lead author: Pottumarthy S, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Global Evaluation of Gemifloxacin Activity Tested Against Community-acquired Respiratory Tract Pathogens, Haemophilus influenzae and Moraxella catarrhalis (1999-2004), Lead author: Ross JE, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Efficacy of Tigecycline Tested Against Community-acquired Respiratory Tract Infection and Nosocomial Pneumonia Pathogens, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Activity of Tigecycline Tested Against an International Collection (1999-2003) of Bacterial Pathogens, Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Changing Antimicrobial Susceptibility Patterns Among S. pneumoniae and H. influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Contemporary Activity of Gemifloxacin and Other Fluoroquinolones Tested Against Streptococcus pneumoniae Isolated During 1999-2004 in Europe and the Americas, Lead author: Biedenbach DJ, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Daptomycin Tested Against 915 Bloodstream Isolates of Viridans Group Streptococci (Eight Species) and Streptococcus Bovis, Lead author: Streit J, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Evaluation of the Peptide Deformylase Inhibitor LBM415 in Combination with Aztreonam to Determine the Synergistic Potential Against Gram-positive and Gram-negative Pathogens, Lead author: Biedenbach DJ, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of LBM415 (NVP PDF-713) Against a Recent (2003) International Collection of Gram-positive and Respiratory Tract Pathogens, Lead author: Watters A, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of Daptomycin Tested Against Gram-positive Strains Collected from European Medical Centres in 2004, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of Garenoxacin, a Novel Des-F(6)-quinolone, and Other Orally Administered Antimicrobials Tested Against 50,217 Enterobacteriaceae Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency of Garenoxacin, a New Des-F(6)-quinolone, Tested Against Community-acquired Respiratory Tract Infection Pathogens Worldwide (29,837 Strains): Report from the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Garenoxacin Activity Against Isolates from Patients Hospitalised with Community-acquired Pneumonia (Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis; 3,087 strains): Report from the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency and Spectrum of Garenoxacin Tested Against an International Collection of Skin and Soft Tissue Infection Pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Susceptibility of 5,859 non-Enterobacteriaceae Gram-negative Organisms Other than Pseudomonas aeruginosa Tested Against the Novel Des-F(6)-quinolone, Garenoxaxin (SENTRY Antimicrobial Surveillance Program, 1999-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Delayed Resistance Selection for Doripenem when Passaging P. aeruginosa Isolates with an Aminoglycoside, Lead author: Biedenbach DJ, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Linezolid Susceptibility Testing Results in Europe: Report from the Worldwide ZAAPS Program (2003), Lead author: Ross JE, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Significant Increases in the Rate of Fluoroquinolone Resistance Among Gram-negative Bacilli: Six-year (1999-2004) Report from the USA MYSTIC Programme, Lead author: Rhomberg PR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Accuracy of Three Automated Systems for Susceptibility Testing Selected Gram-negative Bacilli Against Five Broad-spectrum Beta-Lactam Agents, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Susceptiblity Patterns for Amoxicillin/clavulanate Tests Mimicking Newly Indicated Formulations and Pharmacokinetic Relationships: Does 2:1 Ratio MIC Accurately Reflect Activity Against Beta-Lactamase-Producing H. influenzae and M. catarrhalis, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Diverse Transposons Are Responsible for the Dissemination of Japanese Metallo-beta-lactamase Alleles: Report from the SENTRY Surveillance Programme, Lead author: Toleman MA, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Genetic Characterisation of the IMP-1 Metallo-beta-lactamase Gene in Enterobacter cloacae Strains from Turkey, Lead author: Toleman MA, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of Beta-Lactam Antimicrobial Agent Combinations with Aztreonam When Testing Metallo-Beta-Lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp., Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Transfer and Carriage of Naturally Occurring Pseudomonas aeruginosa Plasmids Harbouring Metallo-beta-lactamase to Enterobacteriaceae Strains, Lead author: Castanheira M, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Antimicrobial Activity of Tigecycline Tested Against Bacterial Pathogens from Intensive Care Units, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Potency and Spectrum of Tigecycline Tested Against an International Collection (1999-2003) of Bacterial Pathogens Producing Skin and Soft Tissue Infections, Lead author: Fritsche TR, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Tigecycline Activity Tested Against 22,950 Bloodstream Infection Isolates Worldwide, Lead author: Jones RN, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

In Vitro Activity of New Compounds Tested Against Multi-Drug Resistant S. aureus Isolated in Latin American Medical Centers (LAMCs), Lead author: Gales AC, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Bactericidal Activity of Vancomycin and Daptomycin Tested Against Heterogeneous and Homogeneous Vancomycin-intermediate S. aureus (hVISA and VISA) Stains, Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark

Update on the Activity of a Topical Triple Antibiotic Ointment Against Cutaneous Pathogens, Lead author: Jones RN, presented at 63rd annual American Academy of Dermatology Annual Meeting (AAD), February 18 – 22, 2005, New Orleans, Louisiana

Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by DiPersio JR, Deshpande LM, Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1): 1-7

Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: Validation report from the SENTRY Antimicrobial Surveillance Program. by Pottumarthy S, Fritsche TR, Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1):57-62

Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections. by Sader HS, Biedenbach DJ, Streit JM and Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (1): 89-92